Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A minor revision update is shown: Revision: v3.3.4 has been added (replacing v3.3.3), and it does not affect substantive content on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:46:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California as a listed study site, clarifying where the trial is conducted. Removed the older California Locations label and the HHS Vulnerability Disclosure link as part of the prior revision.
    Difference
    0.2%
    Check dated 2025-12-24T11:56:01.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The terms 'Head and neck squamous cell carcinoma' and the related topic 'MedlinePlus Genetics' have been removed from the page.
    Difference
    0.2%
    Check dated 2025-12-02T17:23:39.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Related topics were added (Head and neck squamous cell carcinoma; MedlinePlus Genetics) and the page revision label updated from v3.2.0 to v3.3.2. These are metadata updates and do not affect the study details.
    Difference
    0.2%
    Check dated 2025-11-25T13:31:29.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which was an operational status message. This change does not affect the study details or eligibility information, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:39.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The related topics list on the page no longer includes 'Head and neck squamous cell carcinoma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-11T03:13:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.